Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau;Erfolgreiche etanercepttherapie bei therapierefraktärer acrodermatitis continua suppurativa hallopeau

JDDG - Journal of the German Society of Dermatology

Volumn 5, Issue 6, 2007, Pages 489-492

  Weisshaar, Elke ^a   Diepgen, Thomas L ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Acrodermatitis continua suppurativa Hallopeau; Biological therapy; Etanercept; Pustular psoriasis

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; ETANERCEPT; ETRETIN; GLUCOCORTICOID; HYDROCORTISONE BUTYRATE; RETINOID; TACROLIMUS;

ACRODERMATITIS; ADULT; ALOPECIA; ANAMNESIS; ARTHRALGIA; ARTICLE; BLEPHARITIS; CASE REPORT; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPISTAXIS; ERYTHEMA; FEMALE; HAIR LOSS; HUMAN; INTERPHALANGEAL JOINT; METACARPOPHALANGEAL JOINT; MUCOSAL DRYNESS; PUSTULE; PUVA; RADIODIAGNOSIS; SKIN FRAGILITY; XEROPHTHALMIA;

ACRODERMATITIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 34250302728     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2007.06332.x     Document Type: Article

References (10)

1. Weisshaar E, Radulescu M, Bock M, Albrecht U, Diepgen TL. Educational and dermatological aspects of secondary individual prevention in health care workers. Contact Dermatitis 2006; 54: 254-260.
2. Behrens S, von Kobyletzki G, Hoffmann K, Altmeyer P, Kerscher M. PUVA-Bad-Photochemotherapie bei Acrodermatitis continua suppurativa Hallopeau. Hautarzt 1997; 48: 824-827.
3. Wilsmann-Theis D, Hagemann T, Dederer H, Wenzel J, Bieber T, Novak N. Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1 % ointment. Br J Dermatol 2004; 150: 1194-1197.
4. Van Dooren-Greebe RJ, Van de Kerkhof PC, Chang A, Happle R. Acitretin monotherapy in acrodermatitis continua Hallopeau. Acta Derm Venereol 1989; 69: 344-346.
5. Boehncke W-H, Brasie RA, Barker J, Chimenti S, Daudén E, de Rie M, Dubertret L, Giannetti A, Katsambas A, Kragballe K, Naeyaert JM, Ortonne J-P, Peyri J, Prinz JC, Saurat J-H, Strohal R, Van de Kerkhof P, Sterry W. Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus. JEADV 2006; 20: 988-998.
6. Wozel G. Etanercept. Ein effektiver TNF-alpha-Antagonist zur Behandlung von Psoriasisarthritis und Psoriasis vulgaris. Hautarzt 2005; 56: 819-830.
7. Mang R, Ruzicka T, Stege H. Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-α inhibitor infliximab (Remicade® ). Br J Dermatol 2004; 150: 379-80.
8. Tobin AM, Kirby B. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin. Br J Dermatol 2005; 153: 445-446.
9. Kazinski K, Joyce KM, Hodson D. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of Hallopeau. J Drugs Dermatol 2005; 4: 360-364.
10. Nikkels AF, Pierard GE: Etanercept and recalcitrant acrodermatitis continua of Hallopeau. J Drugs Dermatol 2006; 5: 705-706.